LysRs-IN-2
LysRs-IN-2 is a lysyl-tRNA synthetase (KRS) inhibitor with IC50s of 0.015 μM and 0.13 μM for Plasmodium falciparum lysyl-tRNA synthetase (PfKRS) and Cryptosporidium parvum lysyl-tRNA synthetase (CpKRS), respectively[1].
Product Specifications
CAS Number
2170696-76-9
UNSPSC
12352005
Target
Aminoacyl-tRNA Synthetase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/lysrs-in-2.html
Purity
99.92
Solubility
DMSO : ≥ 60 mg/mL
Smiles
FC1=CC=C(OC(C(NCC2(O)CCC(F)(F)CC2)=O)=CC3=O)C3=C1
Molecular Formula
C17H16F3NO4
Molecular Weight
355.31
References & Citations
[1]Baragaña B, et al. Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis. Proc Natl Acad Sci U S A. 2019 Apr 2;116 (14) :7015-7020.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E14429c 96 Tests
ELISA Kit For Hematopoietically-expressed homeobox protein HHEX
Sign In for Pricing
View Details 
![Human Monoclonal Carbonic Anhydrase IX/CA9 Antibody (girentuximab) [Janelia Fluor 669]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
NBP3-28076JF669 0.1 mL
Human Monoclonal Carbonic Anhydrase IX/CA9 Antibody (girentuximab) [Janelia Fluor 669]
Sign In for Pricing
View Details